Surya Pharmaceutical Ltd


BSE: 532516 | NSE: SURYAPHARM | ISIN: INE249G01020 
Market Cap: [Rs.Cr.] 15 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Equity Capital Structure

(Rs.in Cr)  
Year Authorised Issued Subscribed Called Up Less : Calls
in Arrears
Forfeited Paid Up
2012 100.00 20.28 20.28 20.28 0.00 0.00 20.28
2011 100.00 19.28 19.28 19.28 0.00 0.00 19.28
2010 50.00 14.47 14.47 14.47 0.00 0.00 14.47
2009 50.00 14.47 14.47 14.47 0.00 0.00 14.47
2008 26.00 14.47 14.47 14.47 0.00 0.00 14.47
2007 26.00 14.47 14.47 14.47 0.00 0.00 14.47
2006 26.00 11.08 11.08 11.08 0.00 0.00 11.08
2005 15.00 10.68 10.68 10.68 0.00 0.00 10.68
2004 11.00 10.47 10.47 10.47 0.00 0.00 10.47
2003 8.00 7.46 7.46 7.46 0.00 0.00 7.46
2002 6.00 5.75 5.75 5.75 0.00 0.00 5.75
2001 6.00 5.75 5.75 5.75 0.00 0.00 5.75
2000 6.00 4.95 4.95 4.95 0.00 0.00 4.95
1999 6.00 3.37 3.37 3.37 0.00 0.00 3.37
1998 6.00 3.37 3.37 3.37 0.00 0.00 3.37

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 100,567.12 194.61 12.91 27.45 26.1 27.0 0.01
Dr Reddy's Labs 36,245.70 28.64 4.76 18.79 14.3 16.6 0.25
Cipla 30,490.13 20.23 3.44 14.11 15.9 19.8 0.03
Cadila Health. 15,951.29 34.19 5.54 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,579.46 40.36 6.17 23.94 12.7 11.7 0.39
Ranbaxy Labs. 14,910.04 0.00 7.76 72.87 0.0 0.0 2.38
Wockhardt 12,193.51 33.10 14.90 12.82 237.0 30.3 2.09
Piramal Enterp. 9,667.98 0.00 0.92 23.66 0.8 2.1 0.07
Ipca Labs. 8,639.02 26.07 5.50 10.09 24.2 23.7 0.49
Torrent Pharma. 6,978.19 12.11 4.23 11.66 29.6 25.5 0.48
Biocon 5,510.00 19.21 2.50 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,278.00 10.64 1.80 22.89 10.7 8.8 1.01
Strides Arcolab 4,987.36 34.00 3.64 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,493.86 15.84 5.42 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Alka Goyal , Executive Director  

Rajiv Goyal , Chairman & Managing Director  

D P Singhal , Independent Director  


Company Head Office / Quarters:
1596 1st Floor,
Bhagirath Palace,
Delhi,
Delhi-110006
Phone :
Fax :
E-mail :
sales@suryapharma.com
rajivg@suryapharma.com
Web : http://www.suryapharma.com
Registrars:
Big Share Services Pvt Ltd
E-2/3 Saki Vihar Rd
Ansa Indl Estate
Saki Naka Andheri-E
Mumbai - 400 072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Foreign Buying Japan Stocks (Yen)
Results
list Coromandel Inter